Ziprasidone
Geodon, Ziprasidone Hydrochloride
Atypical Antipsychotic
NADAC/unit
$0.2702
No Shortage
Tier 1: 101.5%
PA Req: 18.2%
10 Manufacturers
31 ANDAs
Ziprasidone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand Geodon: Generic saves up to 97% per unit
Market Intelligence
2023-06-28 Class I Recall: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Generic Manufacturers
APOTEX INCAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES INCGLAND PHARMA LTDMACLEODS PHARMACEUTICALS LTDMSN LABORATORIES PRIVATE LTDSANDOZ INCSTERISCIENCE PTE LTDVIATRIS SPECIALTY LLCZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.